Dividends & Buybacks · · GlobeNewswire
Autonomix Medical Announces 1-for-21 Reverse Stock Split Effective June 24
AMIXAutonomix Medical, Inc.
Autonomix Medical filed an amendment to its certificate of incorporation to effect a 1-for-21 reverse stock split of its common stock. The split becomes effective at 12:01 am ET on June 24, 2026, with trading resuming on the Nasdaq Capital Market under ticker AMIX and new CUSIP 05330T304. Outstanding shares will decrease from approximately 11.4 million to 543,000, while authorized shares remain at 500 million. Fractional shares are handled via cash payment. Autonomix Medical is a medical device company focused on developing nerve-targeted treatments for pain and other conditions.